The cardiovascular phenotype of adult patients with phenylketonuria A Azabdaftari, M van der Giet, M Schuchardt, JB Hennermann, ... Orphanet journal of rare diseases 14, 1-11, 2019 | 48 | 2019 |
NOX1 is essential for TNFα-induced intestinal epithelial ROS secretion and inhibits M cell signatures NY Hsu, S Nayar, K Gettler, S Talware, M Giri, I Alter, C Argmann, K Sabic, ... Gut 72 (4), 654-662, 2023 | 31 | 2023 |
Monogenic inflammatory bowel disease-genetic variants, functional mechanisms and personalised medicine in clinical practice A Azabdaftari, KDJ Jones, J Kammermeier, HH Uhlig Human Genetics 142 (5), 599-611, 2023 | 11 | 2023 |
Phosphomannomutase 2 (PMM2) variants leading to hyperinsulinism-polycystic kidney disease are associated with early-onset inflammatory bowel disease and gastric antral foveolar … F Kiparissi, A Dastamani, L Palm, A Azabdaftari, L Campos, E Gaynor, ... Human Genetics 142 (5), 697-704, 2023 | 7 | 2023 |
Biallelic known and novel DCDC2 variants in cholestatic liver disease: Phenotype–genotype observations in four children A Azabdaftari, HL Sczakiel, M Danyel, B Kohlmaier, CJ Mache, A Stalke, ... Liver International 43 (5), 1089-1095, 2023 | 5 | 2023 |
Paneth cell dysfunction and the intestinal microbiome in XIAP deficiency A Azabdaftari, HH Uhlig Science Immunology 6 (65), eabm0293, 2021 | 4 | 2021 |
Patient-derived organoid biobank identifies epigenetic dysregulation of intestinal epithelial MHC-I as a novel mechanism in severe Crohn’s Disease TW Dennison, RD Edgar, F Payne, KM Nayak, ADB Ross, A Cenier, ... Gut, 2024 | 3 | 2024 |
Cellular and molecular basis of proximal small intestine disorders T Bildstein, F Charbit-Henrion, A Azabdaftari, N Cerf-Bensussan, ... Nature Reviews Gastroenterology & Hepatology 21 (10), 687-709, 2024 | 2 | 2024 |
Modulation of intestinal IL-37 expression and its impact on the epithelial innate immune response and barrier integrity L Kröhn, A Azabdaftari, J Heuberger, C Hudert, M Zilbauer, T Breiderhoff, ... Frontiers in Immunology 14, 1261666, 2023 | 2 | 2023 |
Evaluation des kardiovaskulären Risikos bei Patienten mit Phenylketonurie A Azabdaftari | | 2018 |